Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Bard wins FDA approval for LifeStream covered iliac stent
C.R. Bard said today that it won pre-market approval from the FDA for its LifeStream covered iliac stent for treating peripheral artery disease.
The PMA covers the treatment of atherosclerotic lesions in common and external iliac arteries with diameters of 4.5mm to 12.0mm and lesion lengths of up to 100mm, Murray Hill, N.J.-based Bard said. Read more
4. Medtronic warns on button glitch with MiniMed 640G insulin pump
Medtronic issued a field safety notice in May, warning users that keypad buttons on its MiniMed 640G insulin pump may become temporarily stuck when the atmospheric pressure around the pump suddenly increases or decreases – like during air travel.
If the keypad buttons are stuck, users may not be able to program a bolus or stop insulin delivery, Medtronic said, but the issue usually resolves itself within 30 minutes. Read more
3. Teleflex says Venture Cath recall is FDA Class I
Teleflex subsidiary Vascular Solutions today updated on a voluntary recall of its Venture Catheters over issues with excess material on the devices, saying that the FDA labeled it as a Class I recall, it’s most serious designation for recalls.
Class I recall designations, the FDA’s most serious classification of recall, are used when there is a reasonable probability that product use could cause serious adverse health consequences or death. Read more
2. Philips picks up EEG dev Electrical Geodesics for $37m
Royal Philips said today it has agreed to acquire Electrical Geodesics for $36.7 million (GBP£ 29 million).
Amsterdam-based Philips said that EGI’s portfolio of EEG hardware, software and acquisition sensors would work to complement its existing imaging tech and advanced informatics portfolio for neurological applications. Read more
1. Medtronic’s board OKs $5B stock buyback, raises dividend 7%
The board of directors at Medtronic OK’d a $5 billion stock buyback program today and raised the medical device maker’s dividend payout by 7%.
The new repurchasing program supersedes a 2015 plan to reacquire 80 million shares, or about 6% of the total at that time. Read more
The post MassDevice.com +5 | The top 5 medtech stories for June 23, 2017 appeared first on MassDevice.
from MassDevice http://ift.tt/2sZMP8t
Cap comentari:
Publica un comentari a l'entrada